pharmaphorum11m
Why non-diabetics using CGM may not be a good idea
The finding is significant because people can use CGM data to make dietary and lifestyle changes, which may be unnecessary, ...
pharmaphorum58m
Bayer reveals phase 3 data for improved MRI contrast agent
The company has reported the first phase 3 results in hand for gadoquatrane, which reduces the dose of gadolinium delivered ...